Zurich Cantonal Bank’s Inovio Pharmaceuticals INO Stock Holding History

Zurich Cantonal Bank’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,289	Closed	-$32.4K	–	2832
2023 Q1	$32.4K	Hold	3,289	–	–	﹤0.01%	2688
2022 Q4	$61.6K	Buy	3,289 +1,006	+44%	+$22.8K	﹤0.01%	2532
2022 Q3	$47K	Hold	2,283	–	–	﹤0.01%	2614
2022 Q2	$47K	Hold	2,283	–	–	﹤0.01%	2610
2022 Q1	$98K	Hold	2,283	–	–	﹤0.01%	2294
2021 Q4	$137K	Buy	2,283 +658	+40%	+$52.7K	﹤0.01%	2333
2021 Q3	$140K	Hold	1,625	–	–	﹤0.01%	2140
2021 Q2	$181K	Sell	1,625 -293	-15%	-$28.1K	﹤0.01%	1867
2021 Q1	$214K	Hold	1,918	–	–	﹤0.01%	1740
2020 Q4	$204K	Buy	1,918 +592	+45%	+$78.8K	﹤0.01%	1828
2020 Q3	$185K	Hold	1,326	–	–	﹤0.01%	1644
2020 Q2	$429K	Buy	+1,326	New	+$213K	﹤0.01%	1087
2019 Q4	–	Sell	-477	Closed	-$12K	–	2605
2019 Q3	$12K	Hold	477	–	–	﹤0.01%	2529
2019 Q2	$17K	Hold	477	–	–	﹤0.01%	2502
2019 Q1	$21K	Hold	477	–	–	﹤0.01%	2400
2018 Q4	$23K	Buy	477 +280	+142%	+$17K	﹤0.01%	2407
2018 Q3	$13K	Hold	197	–	–	﹤0.01%	2528
2018 Q2	$9K	Hold	197	–	–	﹤0.01%	2499
2018 Q1	$11K	Hold	197	–	–	﹤0.01%	2479
2017 Q4	$10K	Hold	197	–	–	﹤0.01%	2498
2017 Q3	$15K	Hold	197	–	–	﹤0.01%	2344
2017 Q2	$18K	Hold	197	–	–	﹤0.01%	2287
2017 Q1	$16K	Hold	197	–	–	﹤0.01%	2371
2016 Q4	$16K	Hold	197	–	–	﹤0.01%	2332
2016 Q3	$22K	Buy	197 +54	+38%	+$5.97K	﹤0.01%	2202
2016 Q2	$16K	Hold	143	–	–	﹤0.01%	2207
2016 Q1	$15K	Hold	143	–	–	﹤0.01%	2212
2015 Q4	$12K	Hold	143	–	–	﹤0.01%	2309
2015 Q3	$10K	Buy	+143	New	+$12.5K	﹤0.01%	2002

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Zurich Cantonal Bank's INO Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 3,289 shares — an estimated $32.4K sold.

Zurich Cantonal Bank first reported a position in INO in Q3 2015 and held it in 29 quarters. The position peaked at $429K in Q2 2020. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

Zurich Cantonal Bank reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 3,289 Inovio Pharmaceuticals shares in Q2 2023, an estimated $32.4K.
Zurich Cantonal Bank first reported a position in Inovio Pharmaceuticals in Q3 2015 and held it in 29 quarters.
Zurich Cantonal Bank's Inovio Pharmaceuticals position peaked at $429K in Q2 2020.
133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.